Long-COVID symptom monitoring: Insights from a two-year telemedicine study
The diverse manifestations of Long-COVID have become increasingly important due to their significant impact on patients' lives. Telemedicine has emerged as an important tool for post COVID-19 follow-up. This study is part of a large cohort study involving COVID-positive patients monitored by th...
Gespeichert in:
| Veröffentlicht in: | PloS one 2024-07, Vol.19 (7), p.e0307834 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 7 |
| container_start_page | e0307834 |
| container_title | PloS one |
| container_volume | 19 |
| creator | Foppiani, Andrea Montanari, Chiara Zanelli, Sara Lombardo, Michele Davide Maria Calcaterra, Valeria Zuccotti, Gianvincenzo |
| description | The diverse manifestations of Long-COVID have become increasingly important due to their significant impact on patients' lives. Telemedicine has emerged as an important tool for post COVID-19 follow-up. This study is part of a large cohort study involving COVID-positive patients monitored by the COD19 telemedicine platform operations center. We recontacted patients who were initially monitored from February 2020 to May 2020 to assess the presence of Long-COVID symptoms at a 2-year follow-up.
We conducted interviews to evaluate Long-COVID symptoms at the 2-year mark and investigated whether patients had contracted a second COVID-19 infection between the 1-year and 2-year follow-ups, and recorded their vaccination status.
Out of 165 patients, 139 (84%) reported symptoms at the 1-year follow-up, while only 101 (61%) reported symptoms at the 2-year follow-up. Among patients with Long-COVID symptoms at the 2-year follow-up, the majority (80, 49%) had experienced Long-COVID at the 1-year follow-up, received the SARS-CoV-2 vaccine, and had not experienced a second infection between the two follow-ups. Both having Long-COVID at the 1-year follow-up and contracting a second infection were significant risk factors for presenting with Long-COVID at the 2-year follow-up.
To the best of our knowledge, this study stands out as one of the few that includes a 2-year follow-up on Long-COVID symptoms using telemedicine. Telemedicine has proven to be an effective and innovative tool for long-term patient monitoring, early diagnosis, and treatment. Telemedicine represents a significant future challenge for healthcare. |
| doi_str_mv | 10.1371/journal.pone.0307834 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_3085092306</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A802710948</galeid><doaj_id>oai_doaj_org_article_5cc5a7596df24203b8211d6349b83973</doaj_id><sourcerecordid>A802710948</sourcerecordid><originalsourceid>FETCH-LOGICAL-c516t-5e81d92954b06c421973bab3ef06f668250b16131a5cdf889415370cca73d45c3</originalsourceid><addsrcrecordid>eNqNkluL1DAYhoso7rr6D0QLguhFx6Q5NPFuGU-VgQEPexvSNO1kaJPZJEXn35txusuO7IXkIuHL8x14vzfLnkOwgKiC77Zu8lYOi52zegEQqBjCD7JzyFFZ0BKgh3feZ9mTELYAEMQofZydIQ4IqzA6z76unO2L5fqq_pCH_biLbsxHZ0103tj-fV7bYPpNDHnn04_M4y9X7LX0edSDHnVrlLE6D3Fq90-zR50cgn423xfZz08ffyy_FKv153p5uSoUgTQWRDPY8pIT3ACqcAl5hRrZIN0B2lHKSgIaSCGCkqi2Y4xjSFAFlJIVajFR6CJ7eay7G1wQswxBIMAI4CUCNBH1kWid3IqdN6P0e-GkEX8DzvdC-mjUoAVRisiKcNp2JU5KNayEsKUI84ahNFmq9Wbu5t31pEMUowlKD4O02k3HtjAthMGEvvoHvX-4mepl6m9s56KX6lBUXDJQVhBwzBK1uIdKp9WjUWnlnUnxk4S3JwmJifp37OUUgqi_f_t_dn11yr6-w260HOImuGGKxtlwCuIjqLwLwevuVngIxMGxN2qIg2PF7NiU9mIWbWqSn26TbiyK_gDRzuGV</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3085092306</pqid></control><display><type>article</type><title>Long-COVID symptom monitoring: Insights from a two-year telemedicine study</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>Public Library of Science (PLoS)</source><creator>Foppiani, Andrea ; Montanari, Chiara ; Zanelli, Sara ; Lombardo, Michele Davide Maria ; Calcaterra, Valeria ; Zuccotti, Gianvincenzo</creator><contributor>Amponsah, Seth Kwabena</contributor><creatorcontrib>Foppiani, Andrea ; Montanari, Chiara ; Zanelli, Sara ; Lombardo, Michele Davide Maria ; Calcaterra, Valeria ; Zuccotti, Gianvincenzo ; Amponsah, Seth Kwabena</creatorcontrib><description>The diverse manifestations of Long-COVID have become increasingly important due to their significant impact on patients' lives. Telemedicine has emerged as an important tool for post COVID-19 follow-up. This study is part of a large cohort study involving COVID-positive patients monitored by the COD19 telemedicine platform operations center. We recontacted patients who were initially monitored from February 2020 to May 2020 to assess the presence of Long-COVID symptoms at a 2-year follow-up.
We conducted interviews to evaluate Long-COVID symptoms at the 2-year mark and investigated whether patients had contracted a second COVID-19 infection between the 1-year and 2-year follow-ups, and recorded their vaccination status.
Out of 165 patients, 139 (84%) reported symptoms at the 1-year follow-up, while only 101 (61%) reported symptoms at the 2-year follow-up. Among patients with Long-COVID symptoms at the 2-year follow-up, the majority (80, 49%) had experienced Long-COVID at the 1-year follow-up, received the SARS-CoV-2 vaccine, and had not experienced a second infection between the two follow-ups. Both having Long-COVID at the 1-year follow-up and contracting a second infection were significant risk factors for presenting with Long-COVID at the 2-year follow-up.
To the best of our knowledge, this study stands out as one of the few that includes a 2-year follow-up on Long-COVID symptoms using telemedicine. Telemedicine has proven to be an effective and innovative tool for long-term patient monitoring, early diagnosis, and treatment. Telemedicine represents a significant future challenge for healthcare.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0307834</identifier><identifier>PMID: 39058743</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Adult ; Aged ; Asymptomatic ; Body mass index ; Cohort Studies ; COVID-19 ; COVID-19 - diagnosis ; COVID-19 - epidemiology ; COVID-19 - virology ; COVID-19 Vaccines ; Development and progression ; Diabetes ; Disease ; Emergency medical care ; Female ; Follow-Up Studies ; Health aspects ; Hospitalization ; Hospitals ; Humans ; Hypertension ; Immunization ; Infection ; Infections ; Interviews ; Long COVID ; Male ; Medical research ; Medicine, Experimental ; Middle Aged ; Monitoring ; Patients ; Post-Acute COVID-19 Syndrome ; Risk factors ; SARS-CoV-2 - isolation & purification ; Severe acute respiratory syndrome coronavirus 2 ; Surveillance ; Telemedicine ; Vaccination ; Ventilators ; Viral diseases</subject><ispartof>PloS one, 2024-07, Vol.19 (7), p.e0307834</ispartof><rights>Copyright: © 2024 Foppiani et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</rights><rights>COPYRIGHT 2024 Public Library of Science</rights><rights>2024 Foppiani et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2024 Foppiani et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c516t-5e81d92954b06c421973bab3ef06f668250b16131a5cdf889415370cca73d45c3</cites><orcidid>0009-0005-7112-0522 ; 0000-0002-2137-5974</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0307834&type=printable$$EPDF$$P50$$Gplos$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0307834$$EHTML$$P50$$Gplos$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,860,2096,2915,23845,27901,27902,79343,79344</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39058743$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Amponsah, Seth Kwabena</contributor><creatorcontrib>Foppiani, Andrea</creatorcontrib><creatorcontrib>Montanari, Chiara</creatorcontrib><creatorcontrib>Zanelli, Sara</creatorcontrib><creatorcontrib>Lombardo, Michele Davide Maria</creatorcontrib><creatorcontrib>Calcaterra, Valeria</creatorcontrib><creatorcontrib>Zuccotti, Gianvincenzo</creatorcontrib><title>Long-COVID symptom monitoring: Insights from a two-year telemedicine study</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>The diverse manifestations of Long-COVID have become increasingly important due to their significant impact on patients' lives. Telemedicine has emerged as an important tool for post COVID-19 follow-up. This study is part of a large cohort study involving COVID-positive patients monitored by the COD19 telemedicine platform operations center. We recontacted patients who were initially monitored from February 2020 to May 2020 to assess the presence of Long-COVID symptoms at a 2-year follow-up.
We conducted interviews to evaluate Long-COVID symptoms at the 2-year mark and investigated whether patients had contracted a second COVID-19 infection between the 1-year and 2-year follow-ups, and recorded their vaccination status.
Out of 165 patients, 139 (84%) reported symptoms at the 1-year follow-up, while only 101 (61%) reported symptoms at the 2-year follow-up. Among patients with Long-COVID symptoms at the 2-year follow-up, the majority (80, 49%) had experienced Long-COVID at the 1-year follow-up, received the SARS-CoV-2 vaccine, and had not experienced a second infection between the two follow-ups. Both having Long-COVID at the 1-year follow-up and contracting a second infection were significant risk factors for presenting with Long-COVID at the 2-year follow-up.
To the best of our knowledge, this study stands out as one of the few that includes a 2-year follow-up on Long-COVID symptoms using telemedicine. Telemedicine has proven to be an effective and innovative tool for long-term patient monitoring, early diagnosis, and treatment. Telemedicine represents a significant future challenge for healthcare.</description><subject>Adult</subject><subject>Aged</subject><subject>Asymptomatic</subject><subject>Body mass index</subject><subject>Cohort Studies</subject><subject>COVID-19</subject><subject>COVID-19 - diagnosis</subject><subject>COVID-19 - epidemiology</subject><subject>COVID-19 - virology</subject><subject>COVID-19 Vaccines</subject><subject>Development and progression</subject><subject>Diabetes</subject><subject>Disease</subject><subject>Emergency medical care</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Health aspects</subject><subject>Hospitalization</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Immunization</subject><subject>Infection</subject><subject>Infections</subject><subject>Interviews</subject><subject>Long COVID</subject><subject>Male</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Middle Aged</subject><subject>Monitoring</subject><subject>Patients</subject><subject>Post-Acute COVID-19 Syndrome</subject><subject>Risk factors</subject><subject>SARS-CoV-2 - isolation & purification</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Surveillance</subject><subject>Telemedicine</subject><subject>Vaccination</subject><subject>Ventilators</subject><subject>Viral diseases</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNqNkluL1DAYhoso7rr6D0QLguhFx6Q5NPFuGU-VgQEPexvSNO1kaJPZJEXn35txusuO7IXkIuHL8x14vzfLnkOwgKiC77Zu8lYOi52zegEQqBjCD7JzyFFZ0BKgh3feZ9mTELYAEMQofZydIQ4IqzA6z76unO2L5fqq_pCH_biLbsxHZ0103tj-fV7bYPpNDHnn04_M4y9X7LX0edSDHnVrlLE6D3Fq90-zR50cgn423xfZz08ffyy_FKv153p5uSoUgTQWRDPY8pIT3ACqcAl5hRrZIN0B2lHKSgIaSCGCkqi2Y4xjSFAFlJIVajFR6CJ7eay7G1wQswxBIMAI4CUCNBH1kWid3IqdN6P0e-GkEX8DzvdC-mjUoAVRisiKcNp2JU5KNayEsKUI84ahNFmq9Wbu5t31pEMUowlKD4O02k3HtjAthMGEvvoHvX-4mepl6m9s56KX6lBUXDJQVhBwzBK1uIdKp9WjUWnlnUnxk4S3JwmJifp37OUUgqi_f_t_dn11yr6-w260HOImuGGKxtlwCuIjqLwLwevuVngIxMGxN2qIg2PF7NiU9mIWbWqSn26TbiyK_gDRzuGV</recordid><startdate>20240726</startdate><enddate>20240726</enddate><creator>Foppiani, Andrea</creator><creator>Montanari, Chiara</creator><creator>Zanelli, Sara</creator><creator>Lombardo, Michele Davide Maria</creator><creator>Calcaterra, Valeria</creator><creator>Zuccotti, Gianvincenzo</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>COVID</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>DOA</scope><orcidid>https://orcid.org/0009-0005-7112-0522</orcidid><orcidid>https://orcid.org/0000-0002-2137-5974</orcidid></search><sort><creationdate>20240726</creationdate><title>Long-COVID symptom monitoring: Insights from a two-year telemedicine study</title><author>Foppiani, Andrea ; Montanari, Chiara ; Zanelli, Sara ; Lombardo, Michele Davide Maria ; Calcaterra, Valeria ; Zuccotti, Gianvincenzo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c516t-5e81d92954b06c421973bab3ef06f668250b16131a5cdf889415370cca73d45c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Asymptomatic</topic><topic>Body mass index</topic><topic>Cohort Studies</topic><topic>COVID-19</topic><topic>COVID-19 - diagnosis</topic><topic>COVID-19 - epidemiology</topic><topic>COVID-19 - virology</topic><topic>COVID-19 Vaccines</topic><topic>Development and progression</topic><topic>Diabetes</topic><topic>Disease</topic><topic>Emergency medical care</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Health aspects</topic><topic>Hospitalization</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Immunization</topic><topic>Infection</topic><topic>Infections</topic><topic>Interviews</topic><topic>Long COVID</topic><topic>Male</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Middle Aged</topic><topic>Monitoring</topic><topic>Patients</topic><topic>Post-Acute COVID-19 Syndrome</topic><topic>Risk factors</topic><topic>SARS-CoV-2 - isolation & purification</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Surveillance</topic><topic>Telemedicine</topic><topic>Vaccination</topic><topic>Ventilators</topic><topic>Viral diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Foppiani, Andrea</creatorcontrib><creatorcontrib>Montanari, Chiara</creatorcontrib><creatorcontrib>Zanelli, Sara</creatorcontrib><creatorcontrib>Lombardo, Michele Davide Maria</creatorcontrib><creatorcontrib>Calcaterra, Valeria</creatorcontrib><creatorcontrib>Zuccotti, Gianvincenzo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Foppiani, Andrea</au><au>Montanari, Chiara</au><au>Zanelli, Sara</au><au>Lombardo, Michele Davide Maria</au><au>Calcaterra, Valeria</au><au>Zuccotti, Gianvincenzo</au><au>Amponsah, Seth Kwabena</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-COVID symptom monitoring: Insights from a two-year telemedicine study</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2024-07-26</date><risdate>2024</risdate><volume>19</volume><issue>7</issue><spage>e0307834</spage><pages>e0307834-</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>The diverse manifestations of Long-COVID have become increasingly important due to their significant impact on patients' lives. Telemedicine has emerged as an important tool for post COVID-19 follow-up. This study is part of a large cohort study involving COVID-positive patients monitored by the COD19 telemedicine platform operations center. We recontacted patients who were initially monitored from February 2020 to May 2020 to assess the presence of Long-COVID symptoms at a 2-year follow-up.
We conducted interviews to evaluate Long-COVID symptoms at the 2-year mark and investigated whether patients had contracted a second COVID-19 infection between the 1-year and 2-year follow-ups, and recorded their vaccination status.
Out of 165 patients, 139 (84%) reported symptoms at the 1-year follow-up, while only 101 (61%) reported symptoms at the 2-year follow-up. Among patients with Long-COVID symptoms at the 2-year follow-up, the majority (80, 49%) had experienced Long-COVID at the 1-year follow-up, received the SARS-CoV-2 vaccine, and had not experienced a second infection between the two follow-ups. Both having Long-COVID at the 1-year follow-up and contracting a second infection were significant risk factors for presenting with Long-COVID at the 2-year follow-up.
To the best of our knowledge, this study stands out as one of the few that includes a 2-year follow-up on Long-COVID symptoms using telemedicine. Telemedicine has proven to be an effective and innovative tool for long-term patient monitoring, early diagnosis, and treatment. Telemedicine represents a significant future challenge for healthcare.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>39058743</pmid><doi>10.1371/journal.pone.0307834</doi><tpages>e0307834</tpages><orcidid>https://orcid.org/0009-0005-7112-0522</orcidid><orcidid>https://orcid.org/0000-0002-2137-5974</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1932-6203 |
| ispartof | PloS one, 2024-07, Vol.19 (7), p.e0307834 |
| issn | 1932-6203 1932-6203 |
| language | eng |
| recordid | cdi_plos_journals_3085092306 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry; Public Library of Science (PLoS) |
| subjects | Adult Aged Asymptomatic Body mass index Cohort Studies COVID-19 COVID-19 - diagnosis COVID-19 - epidemiology COVID-19 - virology COVID-19 Vaccines Development and progression Diabetes Disease Emergency medical care Female Follow-Up Studies Health aspects Hospitalization Hospitals Humans Hypertension Immunization Infection Infections Interviews Long COVID Male Medical research Medicine, Experimental Middle Aged Monitoring Patients Post-Acute COVID-19 Syndrome Risk factors SARS-CoV-2 - isolation & purification Severe acute respiratory syndrome coronavirus 2 Surveillance Telemedicine Vaccination Ventilators Viral diseases |
| title | Long-COVID symptom monitoring: Insights from a two-year telemedicine study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T21%3A08%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-COVID%20symptom%20monitoring:%20Insights%20from%20a%20two-year%20telemedicine%20study&rft.jtitle=PloS%20one&rft.au=Foppiani,%20Andrea&rft.date=2024-07-26&rft.volume=19&rft.issue=7&rft.spage=e0307834&rft.pages=e0307834-&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0307834&rft_dat=%3Cgale_plos_%3EA802710948%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3085092306&rft_id=info:pmid/39058743&rft_galeid=A802710948&rft_doaj_id=oai_doaj_org_article_5cc5a7596df24203b8211d6349b83973&rfr_iscdi=true |